 coopervision lteye delays annual meeting coopervision delayed annual meeting june 22 14 board review recapitalization options meeting coopervision today reported quarter net income 646 mln dlrs 1752 mln dlr pretax gain sale ophthalmic business johnson johnson ltjnj 260 mln dlrs cash 179 mln dlr posttax charge debt repurchase sales 944 mln dlrs year earlier earned 7300000 dlrs 120000 dlr loss discontinued operations sales 854 mln dlrs company aggressive program investment spending maintain increase market shares core businesses accelerate sales growth year hold back increases operating income future coopervision entire net cash proceeds recent sales businesses employed reduce indebtedness make strategic acquisitions andor employed relation recapitalization company recovery net income held back loss tax income ophthalmic pharmaceutical business sold johnson johnson